Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Narender Gavva"'
Autor:
Richard Hargreaves, Karen Akinsanya, Seena K. Ajit, Neel T. Dhruv, Jamie Driscoll, Peter Farina, Narender Gavva, Marie Gill, Andrea Houghton, Smriti Iyengar, Carrie Jones, Annemieke Kavelaars, Ajamete Kaykas, Walter J. Koroshetz, Pascal Laeng, Jennifer M. Laird, Donald C. Lo, Johan Luthman, Gordon Munro, Michael L. Oshinsky, G. Sitta Sittampalam, Sarah A. Woller, Amir P. Tamiz
Publikováno v:
Expert Opinion on Therapeutic Targets. 26:811-822
The Helping to End Addiction Long-termIn 2020, the National Institutes of Health (NIH) held the Target Validation for Non-Addictive Therapeutics Development for Pain workshop to gather insights from key opinion leaders in academia, industry, and vent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a580423b3a5c4e04c717c45c0b1e987
https://doi.org/10.1080/14728222.2022.2147063
https://doi.org/10.1080/14728222.2022.2147063
Autor:
Shan Yu, Matthew Ericson, Andrea Fanjul, Derek M. Erion, Maria Paraskevopoulou, Erin N. Smith, Banumathi Cole, Ryan Feaver, Corine Holub, Narender Gavva, Shane R. Horman, Jie Huang
Publikováno v:
ACS Chemical Biology. 17:918-929
Liver fibrosis progression in chronic liver disease leads to cirrhosis, liver failure, or hepatocellular carcinoma and often ends in liver transplantation. Even with an increased understanding of liver fibrogenesis and many attempts to generate thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74b2f5e9de8fe7b0e417d602e2240b3a
https://doi.org/10.1021/acschembio.2c00006
https://doi.org/10.1021/acschembio.2c00006